|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 750.57 USD | +0.61% |
|
+0.23% | -2.76% |
Chart calendar Regeneron Pharmaceuticals, Inc.
Upcoming events on Regeneron Pharmaceuticals, Inc.
| 2026-04-22 | Information meeting | 08:30 am |
| 2026-04-29 | Earnings presentation | 08:30 am |
| 2026-04-29 | Earnings release - Q1 2026 | ~ 09:30 am |
| 2026-06-12 | Présentation aux Actionnaires / Analystes | 10:30 am |
Past events on Regeneron Pharmaceuticals, Inc.
| 2026-01-30 | Earnings presentation | 08:30 am |
| 2026-01-30 | Earnings release - Q4 2025 | ~ 09:30 am |
| 2025-12-10 | Information meeting | 08:30 am |
| 2025-11-10 | Information meeting | 08:30 am |
| 2025-10-28 | Earnings release - Q3 2025 | ~ 09:30 am |
| 2025-10-28 | Earnings presentation | 08:30 am |
| 2025-08-01 | Earnings presentation | 08:30 am |
| 2025-08-01 | Earnings release - Q2 2025 | ~ 09:30 am |
| 2025-06-13 | Présentation aux Actionnaires / Analystes | 10:30 am |
| 2025-06-13 | Annual General Meeting | 10:30 am |
| 2025-04-29 | Earnings release - Q1 2025 | ~ 09:30 am |
| 2025-04-29 | Earnings presentation | 08:30 am |
Past dividends on Regeneron Pharmaceuticals, Inc.
| 2026-02-20 | Ex-dividend date - 0.94 USD | 12:00 am |
| 2025-11-20 | Ex-dividend date - 0.88 USD | 12:00 am |
| 2025-08-18 | Ex-dividend date - 0.88 USD | 12:00 am |
| 2025-05-20 | Ex-dividend date - 0.88 USD | 12:00 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 117 12 921 1.52% | 14 202 14 159 0.3% | 14 343 14 241 0.72% | 15 727 | 17 350 | 18 751 |
|
EBITDA Million USD | Released Forecast Spread | 5 547 5 452 1.74% | 5 695 5 764 -1.2% | 5 428 5 590 -2.91% | 5 231 | 6 018 | 7 026 |
|
EBIT Million USD | Released Forecast Spread | 5 126 5 082 0.87% | 5 213 5 260 -0.9% | 4 884 4 731 3.23% | 5 106 | 6 309 | 7 153 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 199 4 276 -1.8% | 4 780 4 829 -1.01% | 5 231 5 146 1.64% | 4 793 | 5 738 | 6 546 |
|
Net income Million USD | Released Forecast Spread | 3 954 3 808 3.83% | 4 413 4 519 -2.36% | 4 505 4 366 3.17% | 4 235 | 5 277 | 6 026 |
|
EPS USD | Released Forecast Spread | 34,8 33,9 2.62% | 38,3 38,8 -1.28% | 41,5 41,1 1.04% | 39,0 | 47,5 | 55,2 |
| Announcement Date | 02/02/24 | 04/02/25 | 30/01/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 547 3 387 4.72% | 3 721 3 667 1.47% | 3 789 3 746 1.15% | 3 029 3 239 -6.5% | 3 676 3 278 12.12% | 3 754 3 589 4.6% | 3 884 3 788 2.54% | 3 480 | 3 810 | 4 144 | 4 332 | 4 203 | 4 455 | 4 606 | 4 790 |
|
EBITDA Million USD | Released Forecast Spread | 1 469 1 311 12.09% | 1 581 1 567 0.87% | 1 488 1 549 -3.95% | 1 004 1 105 -9.17% | 1 499 1 110 34.96% | 1 459 1 213 20.28% | 1 466 1 704 -13.98% | 1 445 | 1 527 | 1 788 | 1 812 | ||||
|
EBIT Million USD | Released Forecast Spread | 1 348 1 226 9.96% | 1 459 1 398 4.38% | 1 362 1 377 -1.14% | 877 933 -6.02% | 1 364 974 40.02% | 1 323 1 060 24.77% | 1 321 1 186 11.43% | 945 | 1 179 | 1 461 | 1 514 | 1 440 | 1 614 | 1 701 | 1 930 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 628 1 146 42.08% | 1 493 1 109 34.62% | 958 1 048 -8.55% | 905 1 150 -21.3% | 1 519 923 64.47% | 1 763 955 84.55% | 1 044 826 26.39% | 1 115 | 1 220 | 1 394 | 1 470 | 1 565 | 1 730 | 1 898 | 2 083 |
|
Net income Million USD | Released Forecast Spread | 1 432 1 040 37.7% | 1 341 1 053 27.37% | 918 1 103 -16.83% | 809 785 2.96% | 1 392 727 91.54% | 1 460 858 70.11% | 845 612 38.12% | 866 | 1 076 | 1 291 | 1 277 | 1 303 | 1 460 | 1 519 | 1 647 |
|
EPS USD | Released Forecast Spread | 12,4 8,27 50.11% | 11,5 9,58 20.41% | 8,06 9,07 -11.14% | 7,27 7,06 3% | 12,8 6,83 87.67% | 13,6 8,05 69.16% | 7,86 9,14 -14% | 8,52 | 9,85 | 11,2 | 11,3 | 11,0 | 12,2 | 12,6 | 13,2 |
| Announcement Date | 01/08/24 | 31/10/24 | 04/02/25 | 29/04/25 | 01/08/25 | 28/10/25 | 30/01/26 | - | - | - | - | - | - | - | - |
| 2026-04-20 |  | Annual General Meeting | 02:30 am |
| 2026-04-20 | | Earnings release - Annual 2025 | ~ 03:00 am |
| 2026-04-20 | | Annual General Meeting | 01:30 am |
| 2026-04-20 | | Annual General Meeting | 02:00 am |
| 2026-04-20 | | Annual General Meeting | 03:00 am |
| 2026-04-21 | | Earnings release - Annual 2025 | ~ 03:00 am |
| 2026-04-20 | | Information meeting | 08:30 pm |
| 2026-04-20 | | Earnings release - Annual 2025 | ~ 09:30 pm |
| 2026-04-21 | | Earnings release - Annual 2025 | ~ 03:00 am |
| 2026-04-21 | | Earnings release - Q1 2026 | ~ 12:30 am |
Past sector events for Regeneron Pharmaceuticals, Inc.
| 2026-04-15 | | Earnings presentation | 03:30 am |
| 2026-04-15 | | Earnings presentation | 03:30 am |
| 2026-04-12 | | Earnings presentation | 09:00 pm |
| 2026-04-13 | | Extraordinary General Meeting | 02:00 am |
| 2026-04-10 | | Earnings presentation | 03:00 am |
| 2026-04-10 | | Earnings presentation | 03:00 am |
| 2026-04-10 | | Earnings presentation | 03:00 am |
| 2026-04-09 | | Sales and Revenue Release - Q1 2026 | Day |
| 2026-04-10 | | Annual General Meeting | 02:00 am |
| 2026-04-08 | | Information meeting | 10:00 pm |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- REGN Stock
- Calendar Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
